BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 14510876)

  • 21. Brivudin compared with famciclovir in the treatment of herpes zoster: effects in acute disease and chronic pain in immunocompetent patients. A randomized, double-blind, multinational study.
    Wassilew S;
    J Eur Acad Dermatol Venereol; 2005 Jan; 19(1):47-55. PubMed ID: 15649191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiviral treatment for preventing postherpetic neuralgia.
    Li Q; Chen N; Yang J; Zhou M; Zhou D; Zhang Q; He L
    Cochrane Database Syst Rev; 2009 Apr; (2):CD006866. PubMed ID: 19370655
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of herpes zoster (shingles) and postherpetic neuralgia.
    Stankus SJ; Dlugopolski M; Packer D
    Am Fam Physician; 2000 Apr; 61(8):2437-44, 2447-8. PubMed ID: 10794584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison between famciclovir and valacyclovir for acute pain in adult Japanese immunocompetent patients with herpes zoster.
    Ono F; Yasumoto S; Furumura M; Hamada T; Ishii N; Gyotoku T; Higuchi M; Inokuchi K; Jyo K; Koga H; Komai A; Maruta K; Mashiko T; Mihara T; Miyahara H; Miyasato M; Muto K; Nagase K; Nagata M; Sakihama H; Tanahashi T; Ueda A; Yamakawa K; Ohata C; Dainichi T; Tsuruta D; Hashimoto T
    J Dermatol; 2012 Nov; 39(11):902-8. PubMed ID: 22670895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Postherpetic neuralgia: impact of famciclovir, age, rash severity, and acute pain in herpes zoster patients.
    Dworkin RH; Boon RJ; Griffin DR; Phung D
    J Infect Dis; 1998 Nov; 178 Suppl 1():S76-80. PubMed ID: 9852980
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of herpes simplex and varicella-zoster virus infections.
    Erlich KS
    West J Med; 1997 Mar; 166(3):211-5. PubMed ID: 9143202
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Valacyclovir and famciclovir therapy in herpes zoster.
    Jubelt B
    Curr Neurol Neurosci Rep; 2002 Nov; 2(6):477-8. PubMed ID: 12359099
    [No Abstract]   [Full Text] [Related]  

  • 28. Antiviral therapy of herpes simplex and varicella-zoster virus infections.
    Wutzler P
    Intervirology; 1997; 40(5-6):343-56. PubMed ID: 9675639
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Approaches to the treatment of varicella-zoster virus infections.
    Whitley RJ
    Contrib Microbiol; 1999; 3():158-72. PubMed ID: 10599529
    [No Abstract]   [Full Text] [Related]  

  • 30. The effects of famciclovir and epidural block in the treatment of herpes zoster.
    Ahn HJ; Lim HK; Lee YB; Hwang SM; Lee WS; Ahn SK; Choi EH
    J Dermatol; 2001 Apr; 28(4):208-16. PubMed ID: 11449672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Famciclovir. A review of its pharmacological properties and therapeutic efficacy in herpesvirus infections.
    Perry CM; Wagstaff AJ
    Drugs; 1995 Aug; 50(2):396-415. PubMed ID: 8521764
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel antibacterial agents for skin and skin structure infections.
    Schweiger ES; Weinberg JM
    J Am Acad Dermatol; 2004 Mar; 50(3):331-40; quiz 341-2. PubMed ID: 14988672
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advances and controversies in the antiviral therapy of herpes zoster.
    Cunningham AL; Dwyer DE
    Eur J Clin Microbiol Infect Dis; 1996 Apr; 15(4):273-5. PubMed ID: 8781875
    [No Abstract]   [Full Text] [Related]  

  • 34. Viral infections affecting the skin in organ transplant recipients: epidemiology and current management strategies.
    Tan HH; Goh CL
    Am J Clin Dermatol; 2006; 7(1):13-29. PubMed ID: 16489840
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of linezolid in the treatment of complicated skin and soft tissue infections.
    Peppard WJ; Weigelt JA
    Expert Rev Anti Infect Ther; 2006 Jun; 4(3):357-66. PubMed ID: 16771613
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Varicella zoster virus infections following allogeneic bone marrow transplantation: frequency, risk factors, and clinical outcome.
    Koc Y; Miller KB; Schenkein DP; Griffith J; Akhtar M; DesJardin J; Snydman DR
    Biol Blood Marrow Transplant; 2000; 6(1):44-9. PubMed ID: 10707998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized, double-blind trial of famciclovir versus acyclovir for the treatment of localized dermatomal herpes zoster in immunocompromised patients.
    Tyring S; Belanger R; Bezwoda W; Ljungman P; Boon R; Saltzman RL;
    Cancer Invest; 2001; 19(1):13-22. PubMed ID: 11291551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic approaches to the management of herpes zoster.
    Whitley RJ; Gnann JW
    Adv Exp Med Biol; 1999; 458():159-65. PubMed ID: 10549388
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Linezolid for the treatment of resistant gram-positive cocci.
    Bain KT; Wittbrodt ET
    Ann Pharmacother; 2001 May; 35(5):566-75. PubMed ID: 11346064
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral antivirals revisited in the treatment of herpes zoster: what do they accomplish?
    Nikkels AF; PiƩrard GE
    Am J Clin Dermatol; 2002; 3(9):591-8. PubMed ID: 12444801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.